CL
CLB.US Core Laboratories NV
- Market cap
- USD 417M
- P/E
- 26.8x
- P/B
- 1.49x
- ROE
- 5.1%
- Dividend yield
- 0.45%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is CLB.US undervalued?
Graham numberCLB.US trades 33.0% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Core Laboratories NV fundamental analysis
No fundamental analysis for Core Laboratories NV yet.
Core Laboratories NV stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Core Laboratories NV
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It o…
Full company profileCore Laboratories NV financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Core Laboratories NV annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 595M | 660M | 701M | 668M | 487M | 470M | 490M | 510M | 524M | 527M | 505M |
| Gross Profit | 125M | 161M | 181M | 173M | 102M | 83.8M | 78.9M | 94.0M | 88.4M | 94.3M | 88.3M |
| Operating Income | 86.2M | 112M | 119M | 96.7M | -76.8M | 45.3M | 41.5M | 54.6M | 58.6M | 50.5M | 30.7M |
| EBITDA | 113M | 134M | 142M | 125M | 70.5M | 63.8M | 58.7M | 70.4M | 73.5M | 71.1M | 45.9M |
| Net Income | 63.9M | 83.1M | 79.5M | 102M | -97.6M | 19.7M | 19.5M | 36.7M | 31.4M | 29.7M | 14.1M |
| EPS | 1.45 | 1.88 | 1.79 | 2.28 | -2.17 | 0.42 | 0.42 | 0.77 | 0.66 | 0.64 | 0.30 |
| Balance Sheet | |||||||||||
| Total Assets | 573M | 585M | 649M | 775M | 569M | 581M | 578M | 586M | 590M | 584M | 594M |
| Total Liabilities | 418M | 436M | 488M | 593M | 493M | 420M | 389M | 357M | 333M | 312M | 309M |
| Shareholders' Equity | 155M | 149M | 161M | 178M | 71.5M | 156M | 184M | 225M | 252M | 266M | 278M |
| Cash & Short-term Investments | 14.8M | 14.4M | 13.1M | 11.1M | 13.8M | 17.7M | 15.4M | 15.1M | 19.2M | 22.7M | 21.4M |
| Total Debt | 232M | 244M | 300M | 382M | 327M | 250M | 222M | 215M | 180M | 164M | 162M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 132M | 124M | 112M | 89.5M | 57.9M | 36.6M | 25.0M | 24.8M | 56.4M | 37.0M | 22.3M |
| Capital Expenditure | 11.7M | 18.8M | 21.7M | 22.3M | 11.9M | 13.5M | 10.2M | 10.6M | 13.0M | 14.7M | 28.4M |
| Free Cash Flow | 120M | 105M | 90.1M | 67.3M | 46.0M | 23.0M | 14.7M | 14.2M | 43.4M | 22.3M | 22.3M |
| Ratios | |||||||||||
| ROE | 41.1% | 55.9% | 49.4% | 57.3% | -136.5% | 12.6% | 10.6% | 16.3% | 12.5% | 11.2% | 5.1% |
| ROA | 11.1% | 14.2% | 12.3% | 13.2% | -17.2% | 3.4% | 3.4% | 6.3% | 5.3% | 5.1% | 2.4% |
| Net Profit Margin | 10.7% | 12.6% | 11.3% | 15.3% | -20.0% | 4.2% | 4.0% | 7.2% | 6.0% | 5.6% | 2.8% |
| Debt to Equity | 1.50x | 1.64x | 1.87x | 2.15x | 4.57x | 1.60x | 1.21x | 0.96x | 0.71x | 0.62x | 0.58x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Core Laboratories NV dividends
- Dividend yield
- 0.45%
- Forward dividend
- 0.04 USD
- Payout ratio
- 6.3%
- Ex-dividend date
- Nov 9, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 1.87M | 0.04 | 6.3% |
| 2024 | USD 1.88M | 0.04 | 6.0% |
| 2023 | USD 1.87M | 0.04 | 5.1% |
| 2022 | USD 1.85M | 0.04 | 9.5% |
| 2021 | USD 1.83M | 0.04 | 9.3% |
| 2020 | USD 12.4M | 0.28 | - |
| 2019 | USD 97.6M | 2.19 | 95.7% |
| 2018 | USD 97.3M | 2.19 | 122.3% |
| 2017 | USD 97.1M | 2.19 | 116.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Jul 9, 2010.
Who owns Core Laboratories NV
- Insiders 1.44%
- Institutions 98.57%
- Public & others 0.00%
- Shares outstanding 45.8M
- Free float 45.2M
Top funds holding CLB.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Ariel Fund Investor | 6.47M | 14.13% | 0.00% | Sep 2026 |
| Ariel Appreciation Investor | 1.43M | 3.12% | 0.00% | Sep 2026 |
| iShares Russell 2000 ETF | 1.18M | 2.58% | 0.00% | Oct 2026 |
| Harbor Small Cap Value Instl | 1.10M | 2.41% | -1.90% | Sep 2026 |
| Schroder ISF Global Energy C Acc USD | 1.08M | 2.35% | +5.77% | Sep 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.03M | 2.25% | 0.00% | Sep 2026 |
| Heartland Value Investor | 900K | 1.96% | -35.71% | Sep 2026 |
| Fidelity Small Cap Index | 521K | 1.14% | +2.18% | Aug 2026 |
| Columbia Small Cap Value Discv A | 497K | 1.08% | +0.73% | Sep 2026 |
| Vanguard Explorer Value Inv | 454K | 0.99% | +5.93% | Sep 2026 |
| iShares Russell 2000 Value ETF | 443K | 0.97% | 0.00% | Oct 2026 |
| Vanguard Energy ETF | 438K | 0.96% | -0.20% | Sep 2026 |
| T. Rowe Price US Smlr Coms Eq A | 398K | 0.87% | 0.00% | Sep 2026 |
| Stt Strt®SPDR®S&P®Oil &GasEqpmnt&SvcsETF | 379K | 0.83% | 0.00% | Oct 2026 |
| DFA U.S. Targeted Value I | 335K | 0.73% | 0.00% | Sep 2026 |
| VanEck Oil Services ETF | 304K | 0.66% | +2.08% | Oct 2026 |
| Dimensional US Targeted Value ETF | 289K | 0.63% | +0.02% | Oct 2026 |
| Vanguard Russell 2000 ETF | 271K | 0.59% | +0.95% | Sep 2026 |
| DFA U.S. Small Cap Value I | 257K | 0.56% | +170.58% | Sep 2026 |
| Schwab US Small-Cap ETF™ | 240K | 0.52% | +0.23% | Oct 2026 |
Top institutions holding CLB.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Ariel Investments, LLC | 14.1M | 30.72% | +6.87% | Jun 2026 |
| BlackRock Inc | 7.46M | 16.28% | +3.49% | Jun 2026 |
| Disciplined Growth Investors Inc | 3.04M | 6.64% | -38.38% | Jun 2026 |
| Earnest Partners LLC | 2.94M | 6.42% | -3.76% | Jun 2026 |
| State Street Corp | 2.18M | 4.75% | +5.63% | Jun 2026 |
| CWA Asset Management Group, LLC | 1.76M | 3.83% | +0.81% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 1.62M | 3.53% | +4.52% | Sep 2026 |
| Vanguard Capital Management, LLC | 1.59M | 3.47% | -1.81% | Jun 2026 |
| Schroder Investment Management Group | 1.54M | 3.37% | 0.00% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 1.28M | 2.78% | +1.64% | Jun 2026 |
| Geode Capital Management, LLC | 1.19M | 2.61% | +4.91% | Jun 2026 |
| Gendell Jeffrey L | 1.09M | 2.38% | +68.24% | Jun 2026 |
| Heartland Advisors Inc | 1.06M | 2.31% | +605.54% | Jun 2026 |
| The Goldman Sachs Group Inc | 752K | 1.64% | -11.46% | Jun 2026 |
| Evergreen Capital Management LLC | 670K | 1.46% | 0.00% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 656K | 1.43% | +46.86% | Jun 2026 |
| Northern Trust Corp | 608K | 1.33% | +7.59% | Jun 2026 |
| Charles Schwab Investment Management Inc | 565K | 1.23% | -17.74% | Jun 2026 |
| T. Rowe Price Investment Management,Inc. | 485K | 1.06% | -56.06% | Jun 2026 |
| UBS Group AG | 462K | 1.01% | +6.98% | Jun 2026 |
Core Laboratories NV company profile
- Company name
- Core Laboratories NV
- Ticker
- CLB.US
- Exchange
- USA Stocks
- Listed since
- Sep 20, 1995
- Sector
- Energy
- Industry
- Energy Equipment & Services
- Employees
- 3,300
- Fiscal year end
- December
- Address
- 6316 Windfern Road, Houston, TX, United States, 77040
- Phone
- 713 328 2673
- Website
- corelab.com
About Core Laboratories NV
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
Core Laboratories NV management
6- Mr. Lawrence V. BrunoChairman of the Board, CEO, President & COO · born 1960
- Mr. Christopher Scott HillSenior VP & CFO · born 1970
- Ms. Gwendolyn Y. Gresham M.B.A.Senior Vice President of Corporate Development & Investor Relations · born 1968
- Mr. Mark Damian Tattoli J.D.Senior VP, Secretary & General Counsel · born 1972
- Mr. Sow Hang TeoVP, Treasurer & Chief Accounting Officer · born 1970
- Leslie D. LinklaterVice President of People, Organization & Culture